对高维混合数据进行聚类以揭示亚表型:表型与基因型数据的联合分析
LIPGENE-SU.VI.MAX研究同时记录了高维连续表型数据和分类基因型数据。作者开发了一种新的潜变量模型,采用贝叶斯有限混合模型对参与者进行聚类,并结合变量选择算法和近似BIC-MCMC准则选择最优模型。研究识别出两个聚类或亚表型(「健康」和「有风险」),少量变量被认为具有判别性,同时包括表型和基因型变量。在数据收集7年后对参与者进行随访分析以诊断代谢综合征的存在与否,两个亚表型与7年随访疾病分类高度对应。
要点
- 开发了贝叶斯有限混合模型潜变量框架,可同时处理高维连续表型与分类基因型数据。
- 识别出两个亚表型(「健康」与「有风险」),判别变量同时包含表型和基因型变量。
- 两个亚表型与7年随访时代谢综合征分类高度对应。
核心结论
- 联合考虑表型和基因型数据可将LIPGENE-SU.VI.MAX参与者聚类为两个亚表型,且这两个亚表型与7年随访疾病分类高度对应,突显了表型和基因型因素在代谢综合征中的作用以及该聚类方法在早期筛查中的潜在效用。
研究设计与样本
- 研究基于LIPGENE-SU.VI.MAX研究记录的高维连续表型数据和分类基因型数据。
- 开发了贝叶斯有限混合模型潜变量模型进行聚类,并结合计算高效的变量选择算法。
- 参数估计通过Gibbs抽样算法完成,采用近似BIC-MCMC准则选择最优模型。
主要发现
- 识别出两个聚类或亚表型(「健康」和「有风险」)。
- 少量变量被认为具有判别性,值得注意的是同时包括表型变量和基因型变量。
- 在LIPGENE-SU.VI.MAX数据收集7年后,参与者接受进一步分析以诊断代谢综合征的存在与否。
- 两个发现的亚表型与7年随访疾病分类高度对应。
- 所提方法能够在参与者层面定义亚表型归属的不确定性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The LIPGENE-SU.VI.MAX study, like many others, recorded high-dimensional continuous phenotypic data and categorical genotypic data. LIPGENE-SU.VI.MAX focuses on the need to account for both phenotypic and genetic factors when studying the metabolic syndrome (MetS), a complex disorder that can lead to higher risk of type 2 diabetes and cardiovascular disease. Interest lies in clustering the LIPGENE-SU.VI.MAX participants into homogeneous groups or sub-phenotypes, by jointly considering their phenotypic and genotypic data, and in determining which variables are discriminatory. A novel latent variable model that elegantly accommodates high dimensional, mixed data is developed to cluster LIPGENE-SU.VI.MAX participants using a Bayesian finite mixture model. A computationally efficient variable selection algorithm is incorporated, estimation is via a Gibbs sampling algorithm and an approximate BIC-MCMC criterion is developed to select the optimal model. Two clusters or sub-phenotypes ('healthy' and 'at risk') are uncovered. A small subset of variables is deemed discriminatory, which notably includes phenotypic and genotypic variables, highlighting the need to jointly consider both factors. Further, 7 years after the LIPGENE-SU.VI.MAX data were collected, participants underwent further analysis to diagnose presence or absence of the MetS. The two uncovered sub-phenotypes strongly correspond to the 7-year follow-up disease classification, highlighting the role of phenotypic and genotypic factors in the MetS and emphasising the potential utility of the clustering approach in early screening. Additionally, the ability of the proposed approach to define the uncertainty in sub-phenotype membership at the participant level is synonymous with the concepts of precision medicine and nutrition. Copyright © 2017 John Wiley & Sons, Ltd.
引用
- McParland D, Phillips CM, Brennan L, et al. Clustering high-dimensional mixed data to uncover sub-phenotypes: joint analysis of phenotypic and genotypic data. Stat Med. 2017. PMID: 28664564. doi:10.1002/sim.7371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。